Tomorrow at 4:30 P.M. ET. Q2 Results

[Anonymous]

Wonder if there is any good news? No spin now! Weather was good.

-------------------------------------

LipoScience to Release Second Quarter 2014 Financial Results

The conference call will be hosted by President and Chief Executive Officer and Executive Vice President and Chief Financial Officer.

To participate in the call, please dial (877) 303-2523 (U.S. and Canada) The Conference ID Number is 78879879.

 

[Anonymous]

It'll be interesting to see how bad the HDL loss hurts us even though it won't be fully realized till year end

 

[Anonymous]

Wonder if there is any good news? No spin now! Weather was good.

-------------------------------------

LipoScience to Release Second Quarter 2014 Financial Results

The conference call will be hosted by President and Chief Executive Officer and Executive Vice President and Chief Financial Officer.

To participate in the call, please dial (877) 303-2523 (U.S. and Canada) The Conference ID Number is 78879879.

A new LOW for LIPO

 

[Anonymous]

A new LOW for LIPO was when PH posted his drunk picture of him and his wife

Totally agree

 

[Anonymous]

HDL was the growth engine for years. I wasn't pretty in terms of how they did it. I don't know how anyone slept at night knowing HDL could disappear. I would not have gone public with that very risky situation. Also it is really lame to let down the investors. What did the company accomplish?

 

[Anonymous]

HDL was the growth engine for years. I wasn't pretty in terms of how they did it. I don't know how anyone slept at night knowing HDL could disappear. I would not have gone public with that very risky situation. Also it is really lame to let down the investors. What did the company accomplish?

Just like bioreference.

 

[Anonymous]

Just like bioreference.

So true, they are the next partner to fall, that's why they haven't brought a vantera in house.

 

[Anonymous]

So true, they are the next partner to fall, that's why they haven't brought a vantera in house.

the final blow to the NE if that happens.

 

[Anonymous]

the final blow to the NE if that happens.

And west coast.

 

[Anonymous]

the final blow to the NE if that happens.

Poo poo we've got Lou

 

[Anonymous]

4:30 for a real shit show to start

 

[Anonymous]

Poo poo we've got Lou

Haha love your sarcasm

 

[Anonymous]

They will blame it on sales force 50% target list not getting reached.

 

[Anonymous]

So true, they are the next partner to fall, that's why they haven't brought a vantera in house.

BioRef is keeping LipoScience alive. Growth in NE, Cali, and FL all from BioRef. What makes you think they are falling? Great partner of ours. Does much more for us in said markets then LCA.

 

[Anonymous]

Why is it a good thing that LipoScience partners end up leading sales growth? Liposcience should be driving sales growth. It always comes from elsewhere. Not a good reflection on the company in terms of training and sales leadership.

 

[Anonymous]

Let the chit show begin!!!! It's 4:30

 

[Anonymous]

HDL is all to blame.

Stock closed today at 2.99 let's see it tank over the next few days.

 

[Anonymous]

It's worse then I thought - down 32%

Also said we have 18-24 months till we'll need to raise more capital, ouch!

It's over, no amount of data or clinical outcome will turn this ship around.

 

[Anonymous]

Did they mention the fact that's Boston heart will be our next big loss as they no longer offer a P&H fee? That loss will be substantially felt in Q3!

 

[Anonymous]

No mention or questions around managed care win, vantera placements or lack thee of, Scriptts utilization of the test or acceptance from anyone in general. They got off the hook easy on this call. Very limited questions by investment firms.